Amoxycillin + Clavulanic Acid in pharma franchise in Maharashtra

Amoxycillin + Clavulanic Acid in PCD pharma franchise in Shillong

Amoxycillin + Clavulanic Acid in top pharma company in Varanasi

Amoxycillin + Clavulanic Acid in pcd pharma supplier in Coimbatore

Amoxycillin + Clavulanic Acid in phama franchise company in India
Amoxycillin + Clavulanic Acid in phama distributor in Visakhapatnam

Home/Products /amoxycillin-875mg-clavulanic-acid-125mg-tablet

About the Product

Description


Moxyplit CV 1000 Tablet combines the potent antibiotic Amoxycillin with Clavulanic Acid to effectively treat a wide range of bacterial infections. Amoxycillin works by inhibiting the synthesis of bacterial cell walls, leading to cell death. However, many bacteria produce beta-lactamase, an enzyme that can render Amoxycillin ineffective. To combat this, Clavulanic Acid is included to inhibit beta-lactamase, enhancing the effectiveness of Amoxycillin against resistant bacteria.

This combination is commonly used to treat bacterial infections in the respiratory tract (such as pneumonia, bronchitis), skin and soft tissue infections, urinary tract infections, and ear infections. It is also effective in treating intra-abdominal infections and infections caused by susceptible organisms in both adults and children.

Moxyplit CV 1000 Tablet not only combats the infection effectively but also minimizes the likelihood of developing antibiotic resistance. It falls under the Antibiotic and Antibacterials categories and is widely used in General and Gastroenterology therapeutic areas.

Common side effects associated with Moxyplit CV 1000 Tablet may include nausea, diarrhea, vomiting, fungal infections (in areas such as the mouth, skin folds, or vagina), skin rashes, and vaginitis.

Moxyplit CV 1000 Tablet Indicated for treating bacterial infections of the lungs, ear, nasal sinuses, urinary tract, skin, and soft tissues.

Information regarding the use of Moxyplit CV 1000 Tablet during breastfeeding is not available. Please consult your doctor.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Amoxycillin 875mg + Clavulanic Acid 125mg Tablet in the PCD pharma franchise market?

This antibiotic combination tablet has strong demand in the anti-infective segment, making it a high-moving product for medical distributors, wholesalers, and pharma franchise partners focusing on general medicine and infection care portfolios.

Why should medical distributors include this combination tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for treatment of respiratory tract infections, sinus infections, urinary tract infections, dental infections, skin infections, and other bacterial infections. Amoxycillin helps eliminate bacteria, while Clavulanic Acid enhances antibiotic effectiveness by overcoming bacterial resistance, strengthening a reliable antibiotic product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this antibiotic combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong physician prescription demand, fast-moving anti-infective category, high seasonal infection sales, reliable supply chain support, and good margins when partnering for this antibiotic product.

How can I become a distributor or franchise partner for this tablet?

Medical distributors, stockists, and wholesalers interested in this antibiotic combination tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.